Search for company

Bafna Pharmaceuticals Ltd. (India)

Quote Chart
Quote Summary
Last Price 33.90
Volume 59,013
Turnover 1,978,411
Market Bombay Stock Exchange
Ticker 532989
Market Cap Market Cap 632,450
52 Week High 50.45
52 Week Low 24.30
P/E 10.24
EPS 3.31
Dividend Yield
Bookvalue 1,311,753
Enterprise Value 1,005,845
Quote updated on February 05, 2016
Note: data in INR Thousands.
Select Items to chart them. 2016 H1
Net sales revenue
Total Operating Revenue
Operating profit (EBIT)
Net Profit(Loss)
Total Assets N/A
Total equity
Operating Profit Margin
Return on Sales (ROS)
Return on Equity (ROE)
Debt to equity
Quick ratio
Cash Ratio
Note: units in Thousands. Statement: Non-Audited, Individual
Source: Dion Global Solutions Limited, EMIS Company Database.
Company Description

Bafna Pharmaceuticals Limited engages in the manufacture and sale of pharmaceutical products. The company offers its products in various therapeutic areas, including anti-bacterials, anti-pyretics, antconvulsants, anxiolytics, pain management, anthelmintics, anti-fungal, appetite stimulants, antidiarrhoeals, antiemetics, hypnotics, antacids and anti-ulcerants, vitamin and dietary preparations, cough and cold preparations, anti-asthmatics, calcium preparations, anti-hypertensives, and anti-diabetics. Bafna…

Main Products

Capsules, Syrups, Injections, Tablets,

Contact Information

Legal Address
Bafna Towers,, New No. 68, Old No. 299,    , Thambu Chetty Street
Chennai; Tamil Nadu; Map
Postal Code: 600001
Tel: 25267517/ 42677555/
Fax: 25270992

Full name: Bafna Pharmaceuticals Ltd.

Status: Listed
Legal Form: Public Limited Company
Operational Status: Operational
IN-CIN: L24294TN1995PLC030698
ISIN Code: INE878I01014
Incorporation Date: 1995

Basic Information
Total Employees:
Outstanding Shares:
: ()
Registered Capital:
Financial Auditors:
2014: Imports INR 23,746.31 Thousands
Import connections ('000)
2014: Exports INR 359.18 Thousands
Export connections ('000)
Key Executives
Company Secretary
Ownership Details
General Public
Corporate Actions
EMIS Benchmark Score
EMIS DealWatch Deals
DealMonitor Deal Intents
EMIS DealWatch News
Financial Documents/Annual Reports
Competitors - India

Register Your Interest

Receive our Global EMIS Insider

The Global EMIS Insider is a our monthly source of Emerging Markets Information Service (EMIS) functionality enhancements and new content releases in each of our countries worldwide.
First Name: *
Country: *
Last Name: * Company: *
Email: * Position: *
Security Code: *   * Indicates required field.

EMIS is part of the Euromoney Institutional Investor PLC group of companies. Click here for more details on our group's activities.
We will use the information you provide here to process your order/registration/request including communicating with you about it. If you are registering for a trial, you will receive a follow up email and/or call asking you about your trial. As part of the trial, you may also receive email updates and other features as specified for that product. We may monitor your use of our website(s). As an international group, we may transfer your data on a global basis. Subject to your choices below, we may also use your data for marketing purposes. By submitting your details, you will be indicating your consent to the use of your data as identified here. Further information is set out in our privacy policy on this site.

Please tick if you don't want to receive details of products, services and special offers from our group companies by:

Phone    Fax    Email    Mail

Please tick if you don't want to receive details of relevant products, services and special offers from selected companies outside our group

I have read and agree to the Terms and Conditions.

I have read and agree to the Privacy Policy.